Volume 79, Issue 3
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

There is no abstract available for this article.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. Anglaret X, Chêne G, Attia A, Toure S, Lafont S, Combe P, Manlan K, N’Dri-Yoman T, Salamon R, 1999. Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Côte d’Ivoire: a randomised trial. Lancet 353 : 1463–1468.
    [Google Scholar]
  2. Mermin J, Lule J, Ekwaru JP, Malamba S, Downing R, Ransom R, Kaharuza F, Culver D, Kizito F, Bunnell R, Kogozi A, Nakanjako D, Wafula W, Quick R, 2004. Effect of cotrimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda. Lancet 364 : 1428–1434.
    [Google Scholar]
  3. Mermin J, Ekwaru JP, Liechty CA, Were W, Downing R, Ransom R, Weidle P, Lule J, Coutinho A, Solberg P, 2006. Effect of cotrimoxazole prophylaxis, antiretroviral therapy, and insecticide-treated bednets on the frequency of malaria in HIV-1-infected adults in Uganda: a prospective cohort study. Lancet 367 : 1256–1261.
    [Google Scholar]
  4. Gill CJ, Sabin LL, Tham J, Hamer DH, 2004. Reconsidering cotrimoxazole prophylaxis for HIV-exposed African infants. Bull World Health Organ 82 : 1–7.
    [Google Scholar]
  5. Hamel MJ, Greene C, Chiller T, Ouma P, Polyak C, Otieno K, Williamson J, Shi YP, Feikin DR, Marston B, Brooks JT, Poe A, Zhou Z, Ochieng B, Mintz E, Slutsker L, 2008. Does cotrimoxazole prophylaxis for the prevention of HIV-associated opportunistic infections select for resistant pathogens in Kenyan adults? Am J Trop Med Hyg 79 : 320–330.
    [Google Scholar]
  6. Gill CJ, Mwanakasale V, Fox MP, Chilengi R, Tembo M, Nsofwa M, Chalwe V, Mwananyanda L, Mukwamataba D, Malilwe B, Champo D, Macleod WB, Thea DM, Hamer DH, 2008. Effect of presumptive cotrimoxazole prophylaxis on pneumococcal colonization rates, seroepidemiology, and antibiotic resistance among Zambian infants. Bull World Health Organ (in press).
  7. Ministry of Health, 2006. National Guidelines for Diagnosis, Treatment & Prevention of Malaria for Health Workers. Republic of Kenya, Nairobi: Ministry of Health.
  8. Montanari MP, Cochetti I, Mingoia M, Varaldo PE, 2003. Phenotypic and molecular characterization of tetracycline- and erythromycin-resistant strains of Streptococcus pneumoniae. Antimicrob Agents Chemother 47 : 2236–2241.
    [Google Scholar]
  9. World Health Organization, 2005. Technical Updates on the Integrated Management of Childhood Illness (IMCI). Evidence and Recommendations for Further Adaptations. Geneva, Switzerland: World Health Organization.
  10. Ministry of Health, 2007. Kenya Integrated Management of Childhood Illness Guidelines, 2007. Nairobi, Kenya: Ministry of Health.
  11. Straus WL, Qazi SA, Kundi Z, Nomani NK, Schwartz B, Pakistan Cotrimoxazole Study Group, 1998. Antimicrobial resistance and clinical effectiveness of cotrimoxazole versus amoxicillin for pneumonia among children in Pakistan: randomised controlled trial. Lancet 352 : 270–274.
    [Google Scholar]
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error